Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cystinol long is an herbal pharmaceutical product developed by Schaper & Brümmer, primarily indicated for the irrigation of the urinary tract in cases of inflammatory diseases and as a preventive measure against urinary stones and renal gravel. The active component is a dry extract of goldenrod herb (*Solidago virgaurea*). It exerts aquaretic (diuretic), anti-inflammatory, and mild antispasmodic effects, facilitating the flushing of bacteria and sediment from the bladder and kidneys. It is distinct from the company's 'Cystinol akut' product, which contains bearberry leaf extract for acute bacterial infections. Cystinol long is typically used for long-term management and irrigation therapy to maintain urinary tract health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cystinol long.